Pharmaceuticals

Global Antiandrogen Monotherapy Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19277482 | Published Date: 06-Oct-2021 | No. of pages: 104

Description

The Antiandrogen Monotherapy market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Antiandrogen Monotherapy market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Antiandrogen Monotherapy Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Antiandrogen Monotherapy market are:
Genentech Inc.
Amgen Inc
Sanofi SA
Astellas Pharma Inc.
ANI Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
ALZA Corporation
Abbott Laboratories
Novartis AG
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca Plc
OSI Pharmaceuticals, Inc.
Pfizer Inc.
Progenics Pharmaceuticals, Inc.

Most important types of Antiandrogen Monotherapy products covered in this report are:
Steroidal
Nonsteroidal

Most widely used downstream fields of Antiandrogen Monotherapy market covered in this report are:
Prostate Cancer
Benign Prostatic Hyperplasia
Hirsutism
Hyperandrogenism
Others

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.